2,6-DiaMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine manufacturers
|
| | 2,6-DiaMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Basic information |
| Product Name: | 2,6-DiaMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine | | Synonyms: | 2,6-DiaMinopurine -9-beta-D-(2'-C-Methyl)riboside;2-Amino-2'-C-methyladenosine;2,6-DIAMINO-9-(2-C-METHYL-BETA-D-RIBOFURANOSYL)-9H-PURINE;Adenosine, 2-amino-2'-C-methyl-;2,6-Diamino-9-(2-C-methyl-β-D-ribofuranosyl)-9H-purine;2,6-Diaminopurine -9-beta-D-(2’-b-C-methyl) riboside;(2R,3R,4R,5R)-2-(2,6-Diamino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol;2,6-Diamino-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine | | CAS: | 640725-73-1 | | MF: | C11H16N6O4 | | MW: | 296.28 | | EINECS: | | | Product Categories: | | | Mol File: | 640725-73-1.mol |  |
| | 2,6-DiaMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Chemical Properties |
| | 2,6-DiaMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Usage And Synthesis |
| Uses | 2-Amino-2′-C-methyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2,6-DiaMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Preparation Products And Raw materials |
|